Last reviewed · How we verify

NCT05521919

Acute Plasma Abeta Responses to Stress

Completed NA Last updated 10 December 2025
What this trial tests

NA trial testing Sympathetic Nervous System Activation in Stress Reaction in 38 participants. Completed in 10 December 2024.

Timeline
5 December 2023
Primary endpoint
10 December 2024
10 December 2024

Quick facts

Lead sponsorUniversity of Southern California
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment38
Start date5 December 2023
Primary completion10 December 2024
Estimated completion10 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

Adults 18 to 65, any sex, with Stress Reaction or Stress Physiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress Reaction

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing